Pharmasset
Pharmasset is a pharmaceutical company that was established in 1998. It is primarily known for its research and development of antiviral drugs. The company was acquired by Gilead Sciences in 2012.
History
Pharmasset was founded in 1998 by Raymond Schinazi, Dennis Liotta, and Choongho Lee. The company was initially based in Atlanta, Georgia, and focused on the development of antiviral drugs. In 2004, Pharmasset went public and was listed on the NASDAQ stock exchange.
In 2011, Pharmasset made headlines with its experimental drug sofosbuvir, a potential treatment for hepatitis C. The drug showed promising results in clinical trials, leading to a significant increase in the company's stock price.
In 2012, Pharmasset was acquired by Gilead Sciences, a biopharmaceutical company based in Foster City, California. The acquisition was valued at approximately $11 billion.
Products
Pharmasset's primary focus was on the development of antiviral drugs. The company's most notable product is sofosbuvir, a drug used in the treatment of hepatitis C. Sofosbuvir is a nucleotide analogue that inhibits the hepatitis C virus (HCV) NS5B protein.
Other products developed by Pharmasset include racivir, a drug for the treatment of HIV, and PSI-7977, a drug for the treatment of hepatitis C.
Acquisition by Gilead Sciences
In 2012, Gilead Sciences acquired Pharmasset for approximately $11 billion. The acquisition was primarily driven by Pharmasset's promising hepatitis C drug, sofosbuvir. Following the acquisition, Gilead Sciences continued the development of sofosbuvir, which was eventually approved by the Food and Drug Administration (FDA) in 2013.
Impact
The acquisition of Pharmasset by Gilead Sciences has had a significant impact on the treatment of hepatitis C. Sofosbuvir, the drug developed by Pharmasset, is now a key component of several hepatitis C treatment regimens. The drug has been praised for its high cure rates and low side effects.
See also
References
External links
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
